Donadio investigated whether the presence of underlying CKD may affect the diagnostic performance of two of the most studied biomarkers of cardio-renal damage, namely neutrophil gelatinase-associated lipocalin (NGAL) and brain natriuretic peptide (BNP) [1]. Here, NPPB is linked to chronic kidney disease.